stockportfolio.pro
Tandem Diabetes Care, Inc. Free Cash Flow 2012–2025
Tandem Diabetes Care, Inc. (TNDM) annual free cash flow by fiscal year, computed from SEC filings.
| Fiscal year | Free Cash Flow | Change (YoY) |
|---|---|---|
| FY 2025 | $-29.67M | -694.1% |
| FY 2024 | $4.99M | +108.5% |
| FY 2023 | $-58.61M | -458.1% |
| FY 2022 | $16.37M | -83.2% |
| FY 2021 | $97.18M | +3648.0% |
| FY 2020 | $-2.74M | -112.2% |
| FY 2019 | $22.36M | +297.8% |
| FY 2018 | $-11.30M | +84.3% |
| FY 2017 | $-71.85M | -2.5% |
| FY 2016 | $-70.10M | -8.6% |
| FY 2015 | $-64.53M | +1.9% |
| FY 2014 | $-65.78M | -27.1% |
| FY 2013 | $-51.77M | -36.2% |
| FY 2012 | $-38.00M | — |
Source: Tandem Diabetes Care, Inc. SEC filings — cash flow statement (10-K). Refreshed nightly.
See the full picture for Tandem Diabetes Care, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeTandem Diabetes Care, Inc. — frequently asked questions
What is Tandem Diabetes Care, Inc.'s free cash flow?
Tandem Diabetes Care, Inc. (TNDM) reported free cash flow of $-29.67M for fiscal year 2025, per its SEC filings.
Where does this data come from?
Figures are computed from Tandem Diabetes Care, Inc.'s official SEC filings (cash flow statement (10-K)), refreshed nightly. Not investment advice.